期刊文献+

宫腔镜手术围手术期患者生命体征、血糖及电解质的变化 被引量:4

The Change of vital signs,blood glucose and electrolyte in peri-operative patients undergoing hysteroscope operation
暂未订购
导出
摘要 目的:探讨宫腔镜下围手术期患者生命体征以及血糖、电解质的变化。方法:对158例择期宫腔镜手术患者分别于手术前、手术后10、20、40、60、80 m in观测并记录平均动脉压(MAP)、心率(HR)和中心静脉压(CVP)等指标,并观察血红蛋白(Hb)、红细胞压积(Hct)、血钾(K+)、血钠(Na+)、血氯(C l-)、血钙(Ca2+)和血糖(G lu)等参数变化。结果:在整个手术中过程中,MAP、HR、血糖和CVP等参数在手术开始40 m in后与术前比较明显增高,差异具有统计学意义(P<0.05)。Hb、Hct、Na+和C l-在手术开始40 m in后与术前比较明显下降,差异具有统计学意义(P<0.05)。结论:宫腔镜手术时间越长,出现过度水化综合征的机会越大,因此密切监测生命指标及血糖、血清Na+的变化是至关重要的。 Aim: To observe the change of vital signs,blood glucose and electrolyte in peri-operative patients undergoing hysteroscope operation.Method: One hundred and fifty-eight hysteroscope patients undergoing elective hysteroscope operation were assessed.The changes of MAP, HR,CVP,Hb,Hct,K^+,Na^+,Cl^-,Ca^(2+) and Glu were observed before operation and during operation period at 10,20,40,60 and 80 min.Results:At operation,the changes of MAP,HR and CVP after 40min were signifincantly higher than those before operati...
出处 《暨南大学学报(自然科学与医学版)》 CAS CSCD 北大核心 2006年第4期582-585,共4页 Journal of Jinan University(Natural Science & Medicine Edition)
关键词 宫腔镜手术 血流动力学 电解质 水化综合征 hysteroscope operation hemodynamics electrolyte hyperhydration syndrome
  • 相关文献

参考文献8

二级参考文献59

  • 1冯力民,夏恩兰.宫腔镜电切术中应用5%葡萄糖灌流液的安全性研究[J].中华妇产科杂志,1996,31(5):302-304. 被引量:18
  • 2Kim MR, Kim A, Jo MY, et al. High frequency of endometrial polyps in endometriosis. J Am Assoc Gynecol Laparosc, 2003, 10(1):46-48.
  • 3Taylor LJ, Jackson TL, Reid JG, et al. The differential expression of oestrogen receptors, progesterone receptors, Bcl-2 and Ki-67 in endometrial oolvDs. B JOG, 2003, 110(9):794-798.
  • 4Tallini G, Vanni R, Manfioletti G, et al. HMGI-C and HMGI(Y) immunoreactivity correlates with cytogenetic abnormalities in lipomas,pulmonary chondroid hamartomas, endometrial polyps and uterine leiomyomas and is compatible with rearrangement of the HMGI-C and HMGI(Y) genes. Lab Invest, 2000, 80(1): 359-369.
  • 5Hague S, Manek S, Oehler MK, et al. Tamoxifen induction of angiogenic factor expression in endometrium. Br J Cancer, 2002, 86(5):761-767.
  • 6Chavez NF, Garner EO, Khan W, et al. Does the introduction of new technology change population demographics? Minimally invasive technologies and endometrial polyps. Gynecol Obstet Invest, 2002,54(4): 217-220.
  • 7Savelli L, laco PD, Santini D, et al. Histopathologic features and risk factors for benignity, hyperplasia, and cancer in endometrial polyps. J Am Assoc Gynecol Laparosc, 2003,188(4): 927-931.
  • 8Bouda JJ, Hradecky L, Rokyta Z. Hysteroscopic polypectomy versus fractionated curettage in the treatment of corporal polyps-recurrence of corporal polyps. Ceska Gynekol, 2000, 65(3): 147-151.
  • 9Hachisuga T,Miyakawa T, Tsujioka H, et al. K-ras mutation in tamoxifen-related endometrial polyps. Cancer, 2003, 98(9): 1890-1897.
  • 10Clark TJ, Khan KS, Gupta JK. Current practice for the treatment of benign intrauterine polyps: a national questionnaire survey of consultant gynaecologists in UK. Eur J Obstet Gynecol Reprod Biol, 2002,103(1): 65-67.

共引文献221

同被引文献36

引证文献4

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部